Title : Significant and sustained antitumor activity in post-docetaxel, castration-resistant prostate cancer with the CYP17 inhibitor abiraterone acetate.

Pub. Date : 2010 Mar 20

PMID : 20159823






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Significant and sustained antitumor activity in post-docetaxel, castration-resistant prostate cancer with the CYP17 inhibitor abiraterone acetate. Abiraterone Acetate cytochrome P450 family 17 subfamily A member 1 Homo sapiens
2 PURPOSE: The principal objective of this trial was to evaluate the antitumor activity of abiraterone acetate, an oral, specific, irreversible inhibitor of CYP17 in docetaxel-treated patients with castration-resistant prostate cancer (CRPC). Abiraterone Acetate cytochrome P450 family 17 subfamily A member 1 Homo sapiens